SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-18-027171
Filing Date
2018-04-26
Accepted
2018-04-26 16:10:47
Documents
5
Effectiveness Date
2018-04-26

Document Format Files

Seq Description Document Type Size
1 DEFA14A a18-3016_2defa14a.htm DEFA14A 33054
2 GRAPHIC g30162cai001.gif GRAPHIC 59113
3 GRAPHIC g30162cai002.gif GRAPHIC 87448
4 GRAPHIC g30162cai003.gif GRAPHIC 29411
5 GRAPHIC g30162cai004.gif GRAPHIC 4392
  Complete submission text file 0001104659-18-027171.txt   282942
Mailing Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139 617-349-1971
CATABASIS PHARMACEUTICALS INC (Filer) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37467 | Film No.: 18778628
SIC: 2834 Pharmaceutical Preparations